In vitro imaging of human monocytic cellular activity using superparamagnetic iron oxide

The aim is to evaluate if a difference in activity of monocytic cells can be described on superparamagnetic iron oxide (SPIO)-magnetic resonance imaging (MRI) in vitro when a low concentration of SPIO is administered. Human monocytic cells were stimulated with phorbol 12-myristate 13-acetate (PMA) or left non-stimulated for 24 h and then treated with SPIO with a final concentration of 7.2 microg Fe/ml for 48 h. They were collected, and an MRI phantom was prepared by suspending them in 4% gelatin and scanned using gradient-echo T2*-weighted and spin-echo T2-weighted imaging with two different echo times. The signal intensity and T2*/T2 relaxation times of each layer were also assessed. The number and degree of intracellular filling of cells positively stained with Berlin blue were evaluated microscopically. In addition, the heme oxygenase-1 expression in non-stimulated monocytic cells or monocytic cells stimulated with PMA was evaluated using semiquantitative reverse transcription and polymerase chain reaction. The signal reduction of cells stimulated with PMA was 3.9- to 5.0-fold and 2.7- to 3.1-fold greater than that of non-stimulated cells on the T2*- and T2-weighted images, respectively. These signal reductions were also visually confirmed. Estimated T2*/T2 relaxation times of cells stimulated with PMA and non-stimulated cells were 31.3/137.8 and 122.8/182.6 ms, respectively. Cells positively stained with Berlin blue were observed in 4.5% and 25.3% of non-stimulated cells and those stimulated with PMA, respectively (p<0.05). The intracellular filling in cells stimulated with PMA was significantly larger than that in non-stimulated cells (p<0.05). The expression of the heme oxygenase-1 gene in monocytic cells stimulated with PMA was 2.9-fold greater than that in non-stimulated monocytic cells. SPIO-MRI can visually describe a difference in activity of monocytic cells in vitro when a low concentration of SPIO is administered.

[1]  B. V. Van Beers,et al.  Benign Hepatocellular Tumors: MRI After Superparamagnetic Iron Oxide Administration , 1995, Journal of computer assisted tomography.

[2]  T. Shono,et al.  Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  T. Murakami,et al.  Superparamagnetic iron oxide–enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading , 2000, Hepatology.

[4]  Ernst J. Rummeny,et al.  Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro , 2004, European Radiology.

[5]  H. Bismuth,et al.  Decreased reticuloendothelial phagocytic capacity in cirrhotic and portacaval shunt rats. , 1987, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[6]  J. Hoefs,et al.  The liver‐spleen scan as a quantitative liver function test: Correlation with liver severity at peritoneoscopy , 1995, Hepatology.

[7]  Ulrich Heinzmann,et al.  Targeting of hematopoietic progenitor cells with MR contrast agents. , 2003, Radiology.

[8]  Brian K Rutt,et al.  Imaging single mammalian cells with a 1.5 T clinical MRI scanner , 2003, Magnetic resonance in medicine.

[9]  H. Shinmoto,et al.  Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. , 2002, Radiology.

[10]  S. Shibahara,et al.  Identification of a cis-regulatory element and putative trans-acting factors responsible for 12-O-tetradecanoylphorbol-13-acetate (TPA)-mediated induction of heme oxygenase expression in myelomonocytic cell lines , 1993, Molecular and cellular biology.

[11]  A. Waxman Scintigraphic evaluation of diffuse hepatic disease. , 1982, Seminars in nuclear medicine.

[12]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.